Stage II Breast Cancer: Cherie's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage II
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation and hormone therapy
- Outcome
- Cancer-Free / Remission
Treatment course, step by step
- Removal of the breast and lymph nodes; chemotherapy with docetaxel, cyclophosphamide and doxorubicin; radiotherapy; ongoing hormone therapy.
What happened, in summary
Cherie was 57 when she felt a hard lump in her breast. After receiving a stage 2 breast cancer diagnosis, she sought a second opinion from a more experienced doctor. She also researched her condition and found an estimated 85% 5-year survival rate for people with a similar diagnosis, which helped her better understand the situation.
Her treatment included removal of the breast and lymph nodes, chemotherapy and radiotherapy. The chemotherapy medicines were docetaxel, cyclophosphamide and doxorubicin. Fatigue, hair loss, nausea and vomiting were the most difficult side effects. Cherie also received hormone therapy and continued taking it during remission.
She tried to eat more healthfully and reduced her alcohol intake, although she exercised less during treatment. Cherie described herself as being in remission. She hoped to keep exercising, travel abroad and learn to paint.
Fear of relapse remained a significant concern. Cherie managed it by making time for activities she enjoyed, particularly travel and painting, rather than allowing cancer to dominate every day. She encouraged other patients to treat the diagnosis as a reason to reconsider their priorities, stay engaged with treatment and protect moments of joy.
Where this story comes from
This is a lay summary of an account first published by Our Cancer Stories. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer